In response to complaints from Charlotte-area pharmacists and patients, U.S. Rep. Larry Kissell, D-N.C., has asked the Federal Trade Commission to investigate reports of anti-competitive and deceptive practices by CVS/Caremark.
Click here to read Kissell's letter.
As reported by Karen Garloch today, Kissell's request comes more than three months after Charlotte pharmacist Jesse Pike and two of his customers testified before FTC Chairman Jon Leibowitz about the chain pharmacy's unfair prescription drug pricing and referral patterns.
Kissell asked the FTC to review its decision to allow the 2006 merger of CVS, the largest retail pharmacy chain, and Caremark, the largest pharmacy benefits manager.
Earlier this year, a spokeswoman for CVS/Caremark disagreed with the independent pharmacists' characterization of the chain's business practices. She said its integrated operations “provide greater choice and more convenience for patients.”